National Cerebral and Cardiovascular

Menu

Research Institute

Studies on miRNA biology

Related several publications

  1. Naraba H, Iwai N. Assessment of the microRNA system in salt-sensitive hypertension. Hypertens Res. 2005; 28: 819-826. (Web of Science Citation=21)
  2. Iwai N, Naraba H. Polymorphisms in human pre-miRNAs. Biochem Biophys Res Commun. 2005; 331: 1439-1444. (107)
  3. Kajimoto K, Naraba H, Iwai N. MicroRNA and 3T3-L1 pre-adipocyte differentiation. RNA. 2006; 12: 1626-1632. (83)
  4. Jin ZB, Hirokawa G, Gui L, et al Targeted Deletion of miR-182, an Abundant Retinal MicroRNA. Mol Vis. 2009; 15: 523-33. (23)
  5. Ji X, Takahashi R, Hiura Y, et al. Plasma miR- 208 as a biomarker of myocardial injury. Clin Chem. 2009; 55: 1944-9. (155)
  6. Adachi T, Nakanishi M, Otsuka Y, et al. Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin Chem. 2010; 56: 1183-85. (92)
  7. Fukushima Y, Nakanishi M, Nonogi H, et al. Assessment of plasma miRNAs in congestive heart failure. Circ J 2011; 75: 336-340. (29)
  8. Weng H, Shen C, Hirokawa G, et al. Plasma miR-124 as a biomarker for cerebral infarction. Biomed Res 2011; 32:135-141. (23)
  9. Endo K, Naito Y, Ji X, et al. microRNA 210 as a biomarker for congestive heart failure. Biol Pharma Bull. 2013; 36:48-54 (6)
  10. Endo K, Kito Y, Fukushima Y, et al. Endo K et al. Novel biomarker for acute kidney injury using TaqMan based unmethylated-DNA specific polymerase chain reaction (in press)

last updated:2021/10/01

Site setting